Why the study?
Does intravenous amiodarone therapy cause early malignant torsades de pointes in susceptible patients?
Does intravenous amiodarone therapy cause early malignant torsades de pointes in susceptible patients?
Intravenous amiodarone can cause early malignant torsades de pointes, and readministration remains hazardous even after correcting predisposing factors.
Answers are grounded in this paper and cite their sources.
May warrant close monitoring for early torsades with IV amiodarone; leaves open rechallenge safety after factor correction.
We present a case of early (within the first 24 hours) development of malignant torsades de pointes (TdP) associated with intravenous amiodarone therapy. After correction of predisposing factors (heart failure, hypokalemia, digoxin) amiodarone again resulted in torsades. This observation suggests that in patients who have experienced amiodarone-induced proarrhythmia, amiodarone administration under different, more stable clinical conditions may still be hazardous.
No takes yet. Share an insight, caveat, or question.
Tomcsányi et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: